Automated Dry Heat Diffusion System
SAM.GOV Due: May 30, 2025 at 06:00 PM UTC
In-Active Combined Synopsis/Solicitation Source Url

Summary

The Automated Dry Heat Diffusion System opportunity is a solicitation issued by the FDA for the acquisition of a specialized instrument designed to conduct in vitro diffusion studies of transdermal and topical drug products. This system, which must feature 24 vertical cells, will be utilized to perform extensive diffusion studies lasting approximately 96 hours, allowing for the assessment of drug release and permeation across various barriers. Contractors with expertise in analytical laboratory instrument manufacturing, particularly those familiar with drug delivery systems and capable of providing installation, operation qualification, and training services, are encouraged to bid on this opportunity. The successful contractor will play a crucial role in supporting the FDA's mission to ensure the safety and efficacy of drug products.
Description

The Division of Product Quality Research (DPQR) conducts research on assessing the quality and safety of drug products. One of the on-going research activities is to conduct research on assessing the performance, quality and safety of transdermal and topical drug products. These studies are criti

Entities
HAHSDO
Department of Health and Human Services
FADA
Food and Drug Administration
NAICS
334516
Set Aside
None
Place of Performance
Silver Spring , Maryland 20993
Point of Contact
Full Name Email Phone Type
Amanda Lusk [email protected] primary
Nicholas Bisher [email protected] secondary
Attachments
  • Attachment+A+-+Pricing+Worksheet.pdf
  • Attachment+B+-+52-212-5-Contract-Terms-and-Conditions+w+Deviation.pdf
  • 5-16-2025+RFQ+No.+75F40125Q00181.pdf
  • Attachment+C-+RFQ+Question+Submittal+Form.xlsx